Q32 Bio Inc. (QTTB)Healthcare | Biotechnology | Waltham, United States | NasdaqCM
21.38 USD
+10.17
(90.723%)
⇧
(July 13, 2026, 4 p.m.
EDT)
After hours: 19.92 -1.46 (-1.460%) ⇩ (July 13, 2026, 7:59 p.m. EDT) |
Hot Take ↕ | July 11, 2026, 4:39 a.m. EDT
The recent $55 million private placement and new institutional ownership provide a necessary liquidity floor, preventing a total collapse given the company's strong balance sheet and positive operating cash flow. However, the long-term outlook remains severely compromised by a catastrophic multi-year price trajectory; the stock has lost nearly 99% of its value over the last seven years, with the most recent annual period seeing an 88% decline. While the fundamentals show profitability and a fortress-like cash position, the market has clearly priced in a structural failure or a complete reset of the business model, making this a high-risk speculative play rather than a traditional investment. The options market confirms this tension, with traders buying deep puts to protect against further erosion while dreaming of a miraculous turnaround via distant-dated calls. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.436618 |
| MSTL | 0.474511 |
| AutoARIMA | 0.476060 |
| AutoETS | 0.476062 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 20% |
| H-stat | 83.93 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.036 |
| Excess Kurtosis | -1.78 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 29.465 |
| Revenue per Share | 4.206 |
| Market Cap | 362,528,160 |
| Trailing P/E | 7.69 |
| Forward P/E | -15.06 |
| Beta | -0.27 |
| Profit Margins | 61.86% |
| Website | https://www.q32bio.com |
As of July 11, 2026, 4:39 a.m. EDT: Speculators are positioning defensively with heavy put volume at the $12.5 strike for the October expiration, creating a significant barrier against further downside. Conversely, call interest is skewed toward deep out-of-the-money strikes ($25.00) for later expirations, suggesting speculative hopes for a massive recovery rather than a measured rally. Implied volatility remains extremely low across the board, indicating a lack of pricing for immediate moves despite the recent financing news.
| Attribute | Value |
|---|---|
| 52 Week Change | 4.5221677 |
| Address1 | 830 Winter Street |
| All Time High | 572.4 |
| All Time Low | 1.345 |
| Ask | 24.75 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 656,600 |
| Average Daily Volume3 Month | 808,221 |
| Average Volume | 808,221 |
| Average Volume10Days | 656,600 |
| Beta | -0.272 |
| Bid | 16.06 |
| Bid Size | 2 |
| Book Value | 3.166 |
| City | Waltham |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 21.38 |
| Current Ratio | 5.362 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 22.5 |
| Day Low | 17.281 |
| Debt To Equity | 29.465 |
| Display Name | Q32 Bio |
| Earnings Timestamp End | 1,762,432,200 |
| Earnings Timestamp Start | 1,762,432,200 |
| Ebitda | 21,770,000 |
| Ebitda Margins | 0.40512002 |
| Enterprise To Ebitda | 14.948 |
| Enterprise To Revenue | 6.056 |
| Enterprise Value | 325,423,168 |
| Eps Forward | -1.42 |
| Eps Trailing Twelve Months | 2.78 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 9.9213 |
| Fifty Day Average Change | 11.458699 |
| Fifty Day Average Change Percent | 1.1549594 |
| Fifty Two Week Change Percent | 452.21677 |
| Fifty Two Week High | 22.5 |
| Fifty Two Week High Change | -1.1200008 |
| Fifty Two Week High Change Percent | -0.049777813 |
| Fifty Two Week Low | 1.569 |
| Fifty Two Week Low Change | 19.810999 |
| Fifty Two Week Low Change Percent | 12.626513 |
| Fifty Two Week Range | 1.569 - 22.5 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,522,243,800,000 |
| Float Shares | 2,595,858 |
| Forward Eps | -1.42 |
| Forward P E | -15.056338 |
| Free Cashflow | 9,871,000 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 22 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.71621 |
| Gross Profits | 38,487,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.04244 |
| Held Percent Institutions | 1.12062 |
| Implied Shares Outstanding | 16,956,415 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,711,411,200 |
| Last Split Factor | 1:18 |
| Long Business Summary | Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with alopecia areata and other autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human antiinterleukin-7 receptor alpha antagonist monoclonal antibody which completed Phase 2a clinical trials, designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic dermatitis and alopecia areata. It also develops ADX-096, a C3d mAb CR1 fusion protein for use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition and a range of other indications. The company was founded in 2017 and is based in Waltham, Massachusetts. |
| Long Name | Q32 Bio Inc. |
| Market | us_market |
| Market Cap | 362,528,160 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_669405676 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | 33,243,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 190,081,412 |
| Number Of Analyst Opinions | 4 |
| Open | 18.33 |
| Operating Cashflow | -27,404,000 |
| Operating Margins | 0.39838 |
| Payout Ratio | 0.0 |
| Phone | 781 999 0232 |
| Post Market Change | -1.4604988 |
| Post Market Change Percent | -6.8311453 |
| Post Market Price | 19.9195 |
| Post Market Time | 1,783,987,179 |
| Previous Close | 11.21 |
| Price Hint | 2 |
| Price To Book | 6.7530007 |
| Price To Sales Trailing12 Months | 6.7463417 |
| Profit Margins | 0.61862 |
| Quick Ratio | 4.809 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 10.17 |
| Regular Market Change Percent | 90.7226 |
| Regular Market Day High | 22.5 |
| Regular Market Day Low | 17.281 |
| Regular Market Day Range | 17.281 - 22.5 |
| Regular Market Open | 18.33 |
| Regular Market Previous Close | 11.21 |
| Regular Market Price | 21.38 |
| Regular Market Time | 1,783,972,800 |
| Regular Market Volume | 27,564,473 |
| Return On Assets | 0.18747 |
| Return On Equity | 1.57181 |
| Revenue Per Share | 4.206 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 16,956,415 |
| Shares Percent Shares Out | 0.0399 |
| Shares Short | 677,047 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 861,749 |
| Short Name | Q32 Bio Inc. |
| Short Percent Of Float | 0.083100006 |
| Short Ratio | 1.23 |
| Source Interval | 15 |
| State | MA |
| Symbol | QTTB |
| Target High Price | 20.0 |
| Target Low Price | 10.0 |
| Target Mean Price | 14.25 |
| Target Median Price | 13.5 |
| Total Cash | 50,751,000 |
| Total Cash Per Share | 2.993 |
| Total Debt | 13,646,000 |
| Total Revenue | 53,737,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 2.78 |
| Trailing P E | 7.690647 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 5.450775 |
| Two Hundred Day Average Change | 15.929224 |
| Two Hundred Day Average Change Percent | 2.9223778 |
| Type Disp | Equity |
| Volume | 27,564,473 |
| Website | https://www.q32bio.com |
| Zip | 2,451 |